Variant report
Variant | nsv945930 |
---|---|
Chromosome Location | chr1:47961672-47966404 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F6 | chr1:47961310-47962067 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | MAFK | chr1:47963200-47963378 | Hela-S3 | cervix: | n/a | n/a |
3 | MAFK | chr1:47963119-47963378 | IMR90 | lung: | n/a | n/a |
4 | MAFK | chr1:47963097-47963431 | HepG2 | liver: | n/a | n/a |
5 | MAFK | chr1:47963156-47963355 | HepG2 | liver: | n/a | n/a |
6 | MAX | chr1:47961321-47961686 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | USF1 | chr1:47961289-47961675 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-STIL-8 | chr1:47963566-47964013 | NONHSAT003085 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL21P24 | TF binding region |
ENSG00000221346 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10157710 | chr1:47961691-47961692 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs563934309 | chr1:47961725-47961726 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10158498 | chr1:47961734-47961735 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs10158499 | chr1:47961744-47961745 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs568269493 | chr1:47961773-47961774 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533352243 | chr1:47961777-47961778 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10158500 | chr1:47961779-47961780 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs547094624 | chr1:47961780-47961781 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112668584 | chr1:47961823-47961824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539519044 | chr1:47961831-47961832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557932704 | chr1:47961851-47961852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529144047 | chr1:47961852-47961853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188927133 | chr1:47961892-47961893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs193137938 | chr1:47961938-47961939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184356735 | chr1:47961940-47961941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544500249 | chr1:47961963-47961964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7532110 | chr1:47961964-47961965 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs144343884 | chr1:47961974-47961975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148782402 | chr1:47961997-47961998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142398271 | chr1:47962118-47962119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs151334226 | chr1:47962122-47962123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34067271 | chr1:47962170-47962171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs397863707 | chr1:47962185-47962186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188327966 | chr1:47962192-47962193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561984967 | chr1:47962231-47962232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191633006 | chr1:47962234-47962235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547700263 | chr1:47962255-47962256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565677436 | chr1:47962354-47962355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114078766 | chr1:47962356-47962357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551455374 | chr1:47962357-47962358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569788587 | chr1:47962409-47962410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376459689 | chr1:47962416-47962417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs207460102 | chr1:47962443-47962444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369173145 | chr1:47962451-47962452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183828147 | chr1:47962453-47962454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140704743 | chr1:47962586-47962587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567875226 | chr1:47962610-47962611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188553281 | chr1:47962756-47962757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114730830 | chr1:47962762-47962763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1591658 | chr1:47962802-47962803 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs545002298 | chr1:47962811-47962812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557009614 | chr1:47962849-47962850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575351712 | chr1:47962853-47962854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574783051 | chr1:47962863-47962864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534540633 | chr1:47962913-47962914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550245055 | chr1:47962914-47962915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs397816270 | chr1:47962915-47962916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556493369 | chr1:47963081-47963082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543144712 | chr1:47963105-47963106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181694893 | chr1:47963121-47963122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 17603634 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Muscle-eye-brain disease | 21572526 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Glioblastoma | 20031968 | CNVD |
Leukemia | 18688285 | CNVD |
Rett syndrome | 21593744 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:47960400-47961800 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
2 | chr1:47960800-47962200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr1:47961400-47961800 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
4 | chr1:47961400-47968800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr1:47961600-47963000 | Enhancers | Liver | Liver |
6 | chr1:47963000-47963400 | Weak transcription | Liver | Liver |
7 | chr1:47963400-47964800 | Enhancers | Liver | Liver |
8 | chr1:47966200-47966600 | Enhancers | Gastric | stomach |